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Abstract
It has been hypothesized that components of enzymatic pathways might organize into intracellular assemblies to improve
their catalytic efficiency or lead to coordinate regulation. Accordingly, de novo purine biosynthesis enzymes may form a
purinosome in the absence of purines, and a punctate intracellular body has been identified as the purinosome. We
investigated the mechanism by which human de novo purine biosynthetic enzymes might be organized into purinosomes,
especially under differing cellular conditions. Irregardless of the activity of bodies formed by endogenous enzymes, we
demonstrate that intracellular bodies formed by transiently transfected, fluorescently tagged human purine biosynthesis
proteins are best explained as protein aggregation.
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Introduction
Enzymes have previously been found to organize into intracel-
lular assemblies that may improve their catalytic efficiency or lead
to coordinate regulation. For example, the trypanosome glycolytic
pathway is organized into a glycosome. Similarly, many such
cellular bodies occur naturally, functioning in degradation or
storage (e.g., P bodies [1] or actin bodies [2]).
While such functional bodies continue to be found, it is also the
case that overexpression of proteins in cells can lead to aggregation
[3,4], such as the formation of inclusion bodies. While measuring
the localization of green fluorescent protein (GFP)-tagged proteins,
we identified a surprisingly large number of punctate bodies that
accumulated in yeast cells during nutrient starvation [5]. This led
us to further speculate whether such bodies were representative of
endogenous, functional assemblies, or accidental or pathological
aggregates.
Among .100 proteins forming such bodies, we observed that
the de novo purine biosynthetic enzyme phosphoribosyl pyrophos-
phate amidotransferase (encoded by the yeast gene ADE4,
homolog of the human enzyme PPAT) reversibly formed
intracellular bodies in the presence and absence of adenine. We
initially thought that such bodies might be depots for functional
enzymes, and the observation of intracellular bodies associated
both with the yeast Ade4 and the human PPAT enzyme suggested
the possibility of a functional purine-biosynthetic intracellular
body conserved between yeast and humans. In particular,
Benkovic and co-workers have identified a cellular body
(composed in part of the PPAT enzyme) that they called the
purinosome [6], forming in human cell culture in the absence of
purines, whose assembly has been shown to be assisted by
microtubules and perturbed by casein kinase II inhibitors [7,8]
and which may be under GPCR control [9].
However, the possibility remained that the manipulation of the
gene (via fusion to GFP) or its expression (via transfection and / or
starvation) [6] had led to aggregate formation. Therefore, we
sought to establish whether the observed punctate bodies [6] were
formed by transiently expressing the recombinant enzymes in
cultured cells. We have now characterized punctate formation in
greater depth and devised explicit tests to determine whether the
bodies may have arisen due to non-native protein expression,
stress, or aggregation.
Results and Discussion
We studied the mechanism by which transfected genes encoding
human purine biosynthetic enzymes might be organized into
cellular aggregates, especially under different nutrient conditions.
HeLa and HEK293 cells transiently expressing GFP- or RFP-
tagged purine biosynthetic enzymes were cultured in purine-poor
media. Punctate bodies were observed, resembling those seen by
An et al. [6]. While variable penetrance of different purine
biosynthetic enzymes was confirmed (Fig. 1A,B), we were
surprised to find that this penetrance was largely independent of
the presence or absence of purines in the growth medium (Fig.
1A,B).
We speculated that the formation of the punctate bodies might
be due to factors other than purine starvation. Previously, the
formation of yeast punctate bodies [5] was correlated with protein
aggregation potentials (TANGO scores [10]), which suggested the
possibility that the recombinant human proteins might be
aggregating. Indeed, the fraction of cells in which individual
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purine biosynthetic enzymes formed detectable punctate bodies
correlated well with the predicted aggregation potentials of the
enzymes (Fig. 1C).
If the proximal cause of the formation of punctate bodies was
aggregation, then it seemed likely that: (a) such bodies could be
induced by cellular stress, and (b) such bodies would contain
proteins normally associated with aggregates, such as chaperones
and ubiquitin. Indeed, we found that hydrogen peroxide can
induce the formation of punctate bodies irrespective of the
presence or absence of purines in the medium (Fig. 2). The
punctate bodies appeared to be universally associated with the
chaperone HSP70, as measured by co-transfection with a plasmid
expressing fluorescently-tagged HSP70 (Fig. 3A-I). We similarly
observed the chaperone HSP90 to co-localize to punctate bodies
(Fig. 3J-L). We confirmed these results for endogenous HSP70,
verifying using immunofluorescence that endogenous HSP70
localized with the punctate bodies (Fig. 4A-C). Association with
HSP70 and HSP90 did not appear to be accidental; short-term
treatment of cells with the HSP90 chaperone inhibitor geldana-
mycin increased accumulation of the punctate bodies (Fig. 5A).
However, longer term treatment with low doses of geldanamycin is
known to induce HSP70 chaperone production via hormesis [11],
and accordingly longer term treatment with geldanamycin not
only inhibited the formation of these bodies, but also prevented
their induction by stressors, such as hydrogen peroxide (Fig. 5B).
As heat shock proteins are highly multifunctional and interact
with many proteins in the cell, we further tested whether punctate
bodies might be aggregates by assaying for their association with
ubiquitin. Using immunofluorescence, we observed the co-
localization of endogenous ubiquitin to the punctate bodies (Fig.
4D-F). In contrast, control experiments employing only secondary
antibody or primary antibody targeting the unrelated enzymes
GAPDH or glutamine synthetase showed no such co-localization
with the punctate bodies (Fig. 4G-O). The association with
Figure 1. The formation of intracellular foci by transfected
purine biosynthetic enzymes correlated well with the aggre-
gation potential of the proteins but was not strongly
influenced by purine availability. (A) The frequency with which
intracellular bodies appeared across the population of transfected cells
varied for individual de novo purine biosynthetic enzymes, and did not
depend upon the purine content of the cell growth medium, shown
here for HEK293 cells cultured using the optimized medium formula-
tions as described in the Methods. Unless otherwise specified, for
HEK293 cells assays in this and later figures, 200 ng of DNA were
transfected for each construct. Bars in all experiments represent the
average and +/- 1 s.d. from at least 3 replicates, counting n = 769, 742,
755, 665, 1225, and 1016 cells, respectively. See Methods for
abbreviations of protein names. (B) This trend was similar for HeLa
cells cultured in purine-rich medium versus purine-depleted medium,
formulated as in [6]. Unless otherwise specified, for HeLa cell assays in
this and later figures, 1.6 mg of DNA were transfected for each
construct. Bars in all experiments represent the average and +/- 1 s.d.
from at least 3 replicates, here counting n = 578, 821, 662, 832, 1519,
732, 674, and 791 total cells, respectively. (C) The frequency with which
transfected cells exhibited bodies (shown here for values reported in
[6]) correlated strongly with each protein’s predicted aggregation
potential [10]. For comparison, the unrelated enzyme GAPDH has a
TANGO score of 879.
doi:10.1371/journal.pone.0056203.g001
Figure 2. The cell stressor hydrogen peroxide (H2O2) strongly
induced purine biosynthetic enzyme punctate bodies regard-
less of hypoxanthine (Hx) presence. Base medium is DMEM
supplemented with 10% FBS. As indicated, medium was also
supplemented with 1 mM H2O2 and/or 35 mM Hx as described in
Methods. For HEK293 PPAT-EGFP cells, n= 4419, 2652, 3088, 3182 cells
per bar. For HEK293 PAICS-RFP cells, n= 2970, 1944, 1880, 1760. For
HEK293T PPAT-EGFP cells, n=4537, 2267, 2411, 2947. For HEK293T
PAICS-RFP cells, n=4612, 3660, 4211, 3760. Bars indicate average +/- 1 s.
d. across at least 3 replicates.
doi:10.1371/journal.pone.0056203.g002
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ubiquitin suggested the possible involvement of the ubiquitin-
proteasome proteolytic pathway; consistent with this involvement,
we observed strong induction of punctate body formation by
treatment with the proteasome inhibitor MG-132 (Fig. 6). The
induction of punctate body formation by blocking protein
degradation suggests that punctate bodies form in cases of excess
protein buildup or compromised protein homeostasis, conditions
which can lead to intracellular aggregation of proteins. (Interest-
ingly, cell lines from purine salvage enzyme deficient mice are not
hypersensitive to proteasome inhibitors [12].) Should the punctate
bodies represent large protein aggregates, the bodies would likely
be marked for degradation, consistent with their co-localization
with ubiquitin. Thus, collectively, these data indicate that the
punctate bodies associated strongly with known markers of
aggregation, and that their formation is modulated in a manner
consistent with aggregation [13,14,15,16] .
If the observed bodies resulted from cellular stress and
aggregation, then they might be the natural outcome of individual
enzyme aggregation. If so, we would predict that other purine
biosynthetic enzymes should not co-localize to the same protein
puncta. Indeed, only ,1% on average of co-transfected cells
showed co-localization of different purine biosynthetic enzymes to
the same puncta (Fig. 7, Table S1). As aggregation was
proportional to the expression levels of individual enzymes (Fig.
8) and was stimulated by stress (Fig. 2), this limited co-localization
likely derived from stress-induced co-aggregation. More generally,
co-transfection tended to suppress puncta formation, or individual
enzymes aggregated separately (Table S1). We also attempted to
co-localize endogenous purine biosynthetic enzymes with protein
puncta by use of immunofluorescence with antibodies against
endogenous PPAT, PAICS, and TrifGART (data not shown).
However, we did not find commercial antibodies satisfactory for
immunofluorescence imaging, as all showed speckling in immu-
nofluorescent experiments, irregardless of purine availability, and
no co-localization with transfected recombinant proteins, arguing
that the speckles are immunofluorescence artifacts.
Figure 3. Co-expressed HSP70 and HSP90 chaperones marked
purine biosynthesis bodies. Intracellular bodies formed by (A)
PPAT-EGFP, (D) FGAMS-EGFP and (G) PAICS-RFP co-localized with co-
transfected (B,E) HSP70-RFP or (H) HSP70-GFP, shown here in HeLa
cells. (C, F and I) show merged images. (J-L) Intracellular bodies were
also often observed to co-localize with co-transfected HSP90, shown
here with PPAT-EGFP.
doi:10.1371/journal.pone.0056203.g003
Figure 4. Endogenous markers of aggregated proteins associ-
ated with intracellular foci of transfected purine biosynthetic
enzymes. (A-C) Endogenous HSP70 and (D-F) ubiquitin co-localized
with bodies formed in cells transfected with FGAMS-EGFP, as assayed
using immunofluorescence. Immunofluorescence against endogenous
glutamine synthetase (G-I) or GAPDH (J-L), which are not markers for
protein aggregation, confirmed that these proteins did not co-localize
with the bodies. (M-O) Additional control experiments employing only
the secondary antibodies (tested for both secondary antibodies and
shown here for Alexa Fluor 594-conjugated goat anti-rabbit) exhibited
no positive signal and, with the experiments in panels (G-L), ruled out
the possibility of non-specific antibody-mediated localization to the
bodies.
doi:10.1371/journal.pone.0056203.g004
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We saw additional support for the association between punctate
bodies and cellular stress from time-lapse microscopy experiments
of transfected cells, during which we observed variation both in
punctate body dynamics as well as in cell survival (Fig. 9).
Microscopy analysis of individual transfected cells over the course
of 1-2 hours revealed that transfected cells without punctate bodies
exhibited significantly higher survival rates than cells marked by
punctate bodies (Fig. 10). This difference in survival rate was
largely independent of purine availability, and persisted even when
the cell growth medium was exchanged from purine-depleted to
purine-rich. The observation that cells marked by punctate bodies
died at greater rates than transfected cells lacking such aggregates
suggested that these cells likely experienced greater levels of stress,
although lacking in an established mechanism and known
molecular signals, it is not clear from these data if the punctate
bodies were a cause or consequence of that stress.
Conclusions
These results serve as a cautionary tale for interpreting the
cellular biology of transfected constructs. Our study encompassed
transiently transfected cells expressing recombinant purine bio-
synthetic enzyme constructs, reproducing the conditions in which
the original purinosome body was identified. We did not pursue
the arduous task of generating stable cell lines. However, we point
out that Goolijarsingh et al. [17] have tested a stably transfected
TrifGART HEK293T cell line in which ‘‘the levels of GFP fusion
protein produced within the cells are substantially reduced and are
similar to wild-type levels’’ and found diffused signal throughout
the cytoplasm and an absence of purinosome bodies. Although
their cell growth condition of 7.7% FBS does not to lead easy
Figure 5. Chaperone activity modulated the formation of
intracellular bodies of purine biosynthetic enzymes. (A) Short-
term treatment with the HSP90 chaperone inhibitor geldanamycin
induced puncta formation in a concentration-dependent manner,
shown here for PPAT-EGFP in HEK293T cells. Bars indicate average +/-
1 s. d. across 3 replicates, n = 680, 351, 565, 601, and 616 total cells,
respectively. (B) Low-dosage geldanamycin pre-treatment—known to
induce HSP70 activity [11]—suppressed oxidatively-induced puncta
formation, shown here for PPAT-EGFP in HEK293T cells. Bars indicate
average +/- 1 s. d. across 3 replicates, n = 555, 500, 608, and 601 total
cells, respectively. Results were similar for FGAMS-EGFP in the absence
of hydrogen peroxide (data not shown).
doi:10.1371/journal.pone.0056203.g005
Figure 6. Inhibition of the proteasome with the drug MG-132
induced formation of PPAT-EGFP bodies in a time-dependent
manner. HeLa cells treated with 20 mM MG-132 in DMSO for 1.5 hours,
2.5 hours, 5 hours, and 8 hours showed increasing fractions of the cell
population exhibiting PPAT-EGFP puncta. Control treatments with only
the carrier (DMSO) for 8 hours showed only minimal penetrance,
consistent with no treatment (Fig. 1B). Bars indicate average +/- 1 s. d.
across 3 replicates, n = 625, 793, 1024, 466, and 397 cells, respectively.
doi:10.1371/journal.pone.0056203.g006
Figure 7. Purine biosynthesis enzymes only rarely co-localized
in intracellular bodies, showing even partial co-localization in
no more than 4% of co-transfected cells as assayed in HeLa
cells and quantified in Table S1. The top row shows an example of
partial but minimal co-localization of FGAMS-EGFP and PAICS-RFP
bodies. The middle row shows an example of non-colocalizing FGAMS-
EGFP and ADSL-RFP bodies. The bottom row shows an example of a
more typical case, non-co-localization due to the formation of bodies by
only one protein in doubly-transfected cells, as shown here for PPAT-
EGFP and PAICS-RFP.
doi:10.1371/journal.pone.0056203.g007
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direct comparison with our work or An et al.’s, it still supports our
claim that transient transfection or otherwise out of context
protein expression may play a role in generating punctate bodies.
In this regard, a consideration of the experiments of An et al.
revealed that the purine-deficient medium did not merely lack
purines, but differed in multiple other ways, as well (including the
base medium, FBS concentration, and removal of nutrients up to
25 kDa), from the purine-rich medium, and the resulting cellular
stress may have induced the aggregation of the recombinant
proteins. A further indication that their purine-depleted medium
may have been stress-inducing is their report that HTB-125 cells
did not survive in their purine-depleted medium. These results also
raise interesting questions regarding how growth conditions and
cellular physiology impact the formation of single protein
aggregates in general, especially proteins altered from their native
state, for example whose levels may no longer correspond to
normal, endogenous levels or which are expressed as fusion
proteins. While it may be possible that purinosome bodies may
shift to stress body-like protein complexes with increasing levels of
protein expression or varying methods of cellular insults, we note
that in general, the formation of purinosome bodies did not vary
strongly amongst the different cell lines, and at least for PAICS-
RFP, we observed the recombinant enzyme to be expressed within
two-fold of endogenous levels (Figure S1).
While it is possible that there are indeed endogenous
purinosomes—notably, experiments by An and colleagues [6]
Figure 8. Formation of intracellular bodies in HEK293T cells
scaled with DNA transfected. Among successfully transfected cells,
the fraction of the cell population exhibiting PAICS-RFP puncta
correlated strongly with the quantity of plasmid DNA transfected. Bars
indicate average +/- 1 s. d. across at least 3 replicates, n = 498, 627, and
591 cells, respectively.
doi:10.1371/journal.pone.0056203.g008
Figure 9. Time course imaging reveals that punctate bodies are dynamic, shown here for HeLa cells in purine-depleted medium
transfected with PAICS-RFP grown in two replicate 4 hour time series. Panels (A) and (D) show the time zero condition; panels (B) and (E)
show the same cells as in (A) and (D), respectively, following two hours of growth in the same medium; panels (C) and (F) show the same cells
following two hours of growth after exchanging the growth medium to purine-rich. Cells marked by * display formation of punctate bodies over the
time series, while cells marked by p display variable dynamics of punctate bodies. The # sign marks cells with punctate bodies that die over the
course of the series; the cell marked by d dies in the absence of punctate bodies. Cell death was determined by marked cell shrinkage and membrane
blebbing, detected by differential interference contrast (DIC) microscopy, as in panel (C-DIC), accompanied by markedly increased cellular
fluorescence, easily distinguishable from flat healthy cells and mitotic cells (one is marked bym in panels (C) and (C-DIC)). Notably, punctate bodies
are detectable in both purine-poor and rich media, with some forming even after the shift into purine-rich medium, as for the cell marked * in (E-F).
doi:10.1371/journal.pone.0056203.g009
Figure 10. Transfected cells exhibiting intracellular bodies died
at a significantly greater rate than transfected cells lacking
such bodies, shown here for HeLa cells two hours after either
no treatment or after exchanging the growth medium from
purine-depleted to purine-rich. All comparisons between cells with
and without intracellular bodies are statistically significant (p-values
ranging from 10-4 to ,10-16). Cell death was measured as marked cell
shrinkage and membrane blebbing accompanied by markedly
increased cellular fluorescence during time lapse fluorescence micros-
copy (e.g., as for the example cells in Fig. 9).
doi:10.1371/journal.pone.0056203.g010
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and Baresova and colleagues [18] both present evidence for
intracellular foci composed of endogenous purine biosynthetic
enzymes as detected by immunofluorescence—these additional
data suggest that the formation of punctate bodies in human cell
culture following transient transfection of clones expressing purine
biosynthesis enzymes can possibly be explained as protein
aggregation.
Materials and Methods
Abbreviations of protein names
PPAT, phosphoribosyl pyrophosphate amidotransferase; Trif-
GART, the trifunctional enzyme glycinamide ribonucleotide
(GAR) synthetase, GAR transformylase, and aminoimidazole
ribonucleotide synthetase; FGAMS, formylglycinamidine ribonu-
cleotide synthase; PAICS, the bifunctional enzyme carboxyami-
noimidazole ribonucleotide synthase and succinylaminoimidazo-
lecarboxamide ribonucleotide synthetase; ADSL,
adenylosuccinate lyase; ATIC, the bifunctional enzyme aminoi-
midazolecarboxamide ribonucleotide transformylase and IMP
cyclohydrolase; GFP, green fluorescent protein; RFP, red
fluorescent protein; EFGP, enhanced GFP; GAPDH, glyceralde-
hyde 3-phosphate dehydrogenase; GLNS, glutamine synthetase.
Expression Vectors
The PPAT-EGFP and FGAMS-EGFP expression plasmids
were generously provided by An and Benkovic [6]. The ADSL-
EGFP expression plasmid was constructed by Gateway cloning
into the FGAMS-EGFP expression plasmid, modified to introduce
the Invitrogen pDEST47 Gateway cassette in place of FGAMS.
All other cDNAs were obtained from the human ORFeome
collection (OpenBiosystems) and cloned using Gateway cloning
into either the pcDNA-DEST47 plasmid (Invitrogen) for carboxy-
terminal GFP-tagged expression clones or the pTagRFP-N
plasmid (Evrogen; modified to introduce the Invitrogen pDEST47
Gateway cassette) for carboxy-terminal RFP-tagged expression
clones.
Cell Culture
To replicate conditions reported by An et al. to give rise to the
purinosome bodies, HeLa cells obtained from the American Type
Culture Collection (ATCC) were cultured at 37uC with 5% CO2
in the following medium as previously described [6]: Purine rich
medium: MEM medium supplemented with 10% FBS (fetal
bovine serum) and 50 mg/mL gentamycin sulfate (Invitrogen);
purine-depleted medium: RPMI medium supplemented with 5%
dialyzed FBS and 50 mg/mL gentamycin. FBS was dialyzed
against 100-fold volumes of 0.9% NaCl at 4 uC for 2-4 days using
a 25 kDa molecular weight cut-off (MWCO) dialysis membrane
with daily exchange of the dialysis solution.
As a test of alternate cell lines and matched purine-rich and
purine-depleted media formulations, HEK293 or HEK293T cells
obtained from ATCC were cultured at 37uC with 5% CO2 in the
following media: (1) Optimized purine-rich medium: DMEM
medium supplemented with 10% FBS and 35 mM hypoxanthine,
or (2) Optimized purine-depleted medium: DMEM medium
supplemented with 10% dialyzed FBS. To remove purines but
retain other important factors, FBS was dialyzed against 100-fold
volumes of 0.9% NaCl at 4uC for 2-4 days using a 1 kDa MWCO
dialysis membrane with daily exchange of the dialysis solution
[19,20].
One day prior to transfection, HeLa cells were plated in 6-well
glass bottom plates in either purine-rich or purine-depleted
medium lacking antibiotics. HEK293 or HEK293T cells were
plated in 96-well glass bottom plates in the optimized purine-rich
medium lacking antibiotics. Plasmids were transfected into cells
using Lipofectamine 2000 (Invitrogen) and Opti-MEM reduced
serum medium (Invitrogen) according to the manufacturer’s
instructions. The transfection medium was replaced with fresh
purine-rich or purine-depleted medium 5 hours after transfection.
Immediately before imaging, cells were washed once with their
respective growth medium. Cells were imaged in their respective
growth medium to minimize stress imposed by nutrient shifts. We
note that the imaging medium therefore contained phenol red,
which could potentially reduce the signal-to-noise ratio, but in
practice, we did not experience problems in detecting and
visualizing purinosome bodies. Live cells were imaged ,20-
24 hours after transfection.
For MG-132 experiments, HeLa cells were plated in 96-well
glass bottom plates in DMEM medium supplemented with 10%
FBS. Due to the toxic nature of MG-132, we opted to use a less
toxic transfection reagent than Lipofectamine 2000, and therefore,
we transfected the PPAT-EGFP-expressing plasmid into cells using
Fugene HD (Roche Applied Sciences) and Opti-MEM reduced
serum medium (Invitrogen) using a 2:4.5 DNA to transfection
reagent ratio following the manufacturer’s protocol. The trans-
fection medium was replaced with fresh DMEM+10% FBS about
5 hours following transfection.
Immunofluorescence
For immunofluorescence experiments, cells were fixed with
3.7% methanol-free formaldehyde freshly diluted from 16% stock
(28908, Thermo Scientific) at 37uC for 15-20 minutes, blocked
with 5% goat serum in PBS-T buffer for 30-60 minutes at room
temperature, then incubated with primary antibody overnight at
4uC. Cells were washed with PBS buffer, then incubated with
secondary antibody for 1 hour. Primary antibodies used: HSP70
(ab5439, Abcam), ubiquitin (ab7780, Abcam), GAPDH (sc-32233,
Santa Cruz Biotech.), glutamine synthetase (sc-9067, Santa Cruz
Biotech.). Secondary antibodies used: Alexa Fluor 594-conjugated
goat anti-mouse (Invitrogen), Alexa Fluor 594-conjugated goat
anti-rabbit (Invitrogen). All antibodies were used at the manufac-
turer’s recommended concentrations. We additionally tested the
protocol using 2% methanol-free formaldehyde fixation or 2%
goat serum in PBS-T block at the appropriate steps to find no
appreciable differences.
Tested antibodies that proved unsuitable or inconclusive for
immunofluorescence included the anti-PPAT antibodies sc-
101892 (Santa Cruz Biotech.) and ab71340 (Abcam), the anti-
PAICS antibody sc-16150 (Santa Cruz Biotech.), and the anti-
TrifGART antibody H00002618-M01 (Novus Biologicals).
Western Blot
For western blotting, cells were grown in DMEM media
containing 10% FBS and transfected as described above with
1.6 mg or 200 ng DNA (HeLa or HEK cells, respectively), in
regular 96-well plates (HEK293 and HEK293T) or 6-well plates
(HeLa). Cells were washed with cold PBS buffer then extracted
with Laemmaeli sample buffer containing 5% beta-mercaptoeth-
anol. Total protein was separated on a 4–15% Mini-PROTEAN
TGX precast gel (BioRad) and blotted with PVDF membrane.
Primary antibodies used: anti-PAICS (HPA035895, Sigma) and
anti-GAPDH (sc-32233, Santa Cruz Biotech.). Secondary anti-
bodies: goat anti-rabbit IgG F(ab’)2-HRP (sc-3837, Santa Cruz
Biotech.) and goat anti-mouse IgG F(ab’)2-HRP (sc-3697, Santa
Cruz Biotech.). Membranes were scanned with an ImageQuant
LAS 4000 (GE Healthcare).
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Fluorescent Microscopy of Cells
Live cells were imaged using a Nikon Eclipse TE2000-E
inverted microscope inside a chamber maintained at 37uC and 5%
CO2. Fixed cells were imaged at room temperature without CO2
supplement. Images were acquired using a Photometrics Cascade
II 512 camera and Nikon Plan Apo 40x/0.95, 60x/0.95, 60x/
1.40, or 100x/1.40 objectives. GFP detection was accomplished
using a ET490/20x excitation filter (Chroma Technology),
ET525/36 m emission filter (Chroma Technology) and 89100 bs
dichroic (Chroma Technology), and RFP detection was carried
out using a ET555/25x excitation filter (Chroma Technology),
ET605/52 m emission filter (Chroma Technology) and 89100 bs
dichroic (Chroma Technology). The same excitation and emission
conditions were used for each GFP variant. We did not detect
notable fluorescence emission bleedthrough or photobleaching
with these settings. Filter wheels (Sutter Lambda 10-3), motorized
stage (Prior H117), and image acquisition were driven by NIS
Elements AR Imaging software.
Cell Counts
Cell counts measuring penetrance of punctate bodies reflect
apparently healthy adherent cells only. Mitotic cells (identified as
rounded cells with a visible rod-like central structure spanning the
cell’s DIC image accompanied by a corresponding decrease of
fluorescent signal; see cell m in Fig. 9C and C-DIC for an
example) and dead cells were not counted for measuring
penetrance of punctate body formation. (For the survival rate
analyses only, dead HeLa cells were selected based on dramatic
cell shrinkage, membrane blebbing, and intense fluorescence, e.g.
as seen for the cells marked by # in Fig. 9. We note that it is
nonetheless possible that only a subset of cell death events—those
accompanied by marked visible cellular reorganization—are
counted by this assay.) Cells displaying any morphology of
punctate bodies were counted, regardless of number of punctate
bodies per cell or ranging sizes of those punctate bodies. We
observed a spectrum of morphologies which were dynamic; for
example, over the course of unperturbed growth, we observed
both increases and decreases in the numbers of punctate bodies
per cell. Future work may address and characterize the different
morphologies and kinetics of punctate bodies.
Drug Treatments
For all drug treatments, drugs were diluted to their final
concentrations in prewarmed cell growth medium then added to
cells for the duration of the treatment. Hydrogen peroxide was
added to cells at a concentration of 1 mM for 0.5-1.5 hours before
imaging. For short-term treatment, geldanamycin was added to
cells at the indicated concentrations at the time of post-transfection
medium replacement, and the cells were incubated for 18 hours.
For long-term treatment, geldanamycin was added to cells at the
indicated concentrations 16 hours prior to transfection, for a total
incubation time of 40 hours. MG-132 was added to cells at a final
concentration of 20 mM for the indicated time intervals. Cells were
fixed at each MG-132 time point with 3.7% formaldehyde for 15-
20 minutes and washed 3 times with PBS before imaging.
Supporting Information
Figure S1 Representative expression levels of PAICS-
RFP transfected constructs in comparison to the endog-
enous PAICS protein. HeLa (A,D), HEK293 (B,E) and
HEK293T (C,F), untransfected (U) or transfected with PAICS-
RFP (T) under representative growth conditions are probed with
anti-PAICS antibody. (D-F) Representative variation of construct
expression between independent transfections. Quantified expres-
sion level ratios of PAICS-RFP construct to endogenous PAICS
(G) across all cells, adjusted with respective transfection rates
(ranging from 6-32%) measured by microscopy, show comparable
expression (within two-fold) of the construct and endogenous
enzyme in transfected cells, under conditions (see Methods) in
which PAICS-RFP foci are observed. Expression ratios are
calculated as (PAICS-RFP Western blot intensity)/(endogenous
PAICS Western blot intensity * transfection efficiency). Bars
indicate average +/- 1 s. d. across at least 3 replicates. (H)
Representative HEK293 cells corresponding to the bar in (G) and
showing visible foci. (I) Expression levels of PAICS-RFP are not
strongly altered by hydrogen peroxide and/or hypoxanthine
treatment for HEK293 (lanes 2-5) and HEK293T cells (lanes 1, 6-
9).
(TIF)
Table S1 Co-transfection significantly suppresses for-
mation of intracellular punctate bodies, arguing against
the bodies representing active purinosomes, as quanti-
fied for different purine biosynthetic enzyme pairs,
reporting counts and percentages of successfully co-
transected HeLa cells as a function of protein localiza-
tion.
(XLS)
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